Importance of echographic and endocrine monitoring for the assessment of ovulation by follicle stimulating hormone in polycystic ovarian disease

Publisher Website
Google Scholar
Abstract
Sixteen patients with polycystic ovarian disease (PCOD) were treated for 39 cycles with pure follicle‐stimulating hormone (FSH) for the induction of ovulation. At ovulation time human chorionic gonadotropin (hCG) was administered. Twenty‐one cycles were ovulatory. Twenty‐three were classified as normostimulated (N): six pregnancies and three abortions were observed. In the remaining eight hyperstimulated (H) cycles there were four full‐term pregnancies. Dosage and length of treatment were greater in patients with excess body weight (P < 0.01). H cycles were characterized in respect to N cycles by: (1) higher baseline values of 17‐hydroxy progesterone (17‐OHP) plasma levels and LH/FSH ratios; (2) higher plasma concentrations and rate of increase of 17‐OHP periovulatory levels. E2 plasma levels did not permit a clear differentiation between H and N cycles, and it was not useful for the timely recognition of hyperstimulation. Our data show that a slight controlled degree of ovarian hyperstimulation is beneficial to pregnancy rate and outcome.

This publication has 18 references indexed in Scilit: